Host immune response against Scedosporium species

References

• Cortez KJ, Roilides E, Quiroz-Telles F, et al. Infections caused by Scedosporium spp. Clin Microbiol Rev 2008; 21: 157–197
   PubMed Web of Science ®Google Scholar
• Lamaris GA, Chamilos G, Lewis RE, et al. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006. Clin Infect Dis 2006; 43: 1580–1584
   PubMed Web of Science ®Google Scholar
• Gilgado F, Cano J, Gene J, Guarro J. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol 2005; 43: 4930–4942
   PubMed Web of Science ®Google Scholar
• Salesa R, Burgos A, Ondiviela R, et al. Fatal disseminated infection by Scedosporium inflatum after bone marrow transplantation. Scand J Infect Dis 1993; 25: 389–393
   PubMed Web of Science ®Google Scholar
• Berenguer J, Rodriguez-Tudela JL, Richard C, et al. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group. Medicine (Baltimore) 1997; 76: 256–265
   PubMed Web of Science ®Google Scholar
• Guarro J, Kantarcioglu AS, Horre R, et al. Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist. Med Mycol 2006; 44: 295–327
   PubMed Web of Science ®Google Scholar
• Diamond RD, Clark RA. Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro. Infect Immun 1982; 38: 487–495
   PubMed Web of Science ®Google Scholar
• Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest 1982; 69: 617–631
   PubMed Web of Science ®Google Scholar
• Washburn RG, Gallin JI, Bennett JE. Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and -independent pathways. Infect Immun 1987; 55: 2088–2092
   PubMed Web of Science ®Google Scholar
• Netea MG, Van der Meer JW, Kullberg BJ. Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defence. Clin Microbiol Infect 2006; 12: 404–409
   PubMed Web of Science ®Google Scholar
• van de Veerdonk FL, Kullberg BJ, van der Meer JW, Gow NA, Netea MG. Host-microbe interactions: innate pattern recognition of fungal pathogens. Curr Opin Microbiol 2008; 11: 305–312
   PubMed Web of Science ®Google Scholar
• Waldorf AR. Pulmonary defense mechanisms against opportunistic fungal pathogens. Immunol Ser 1989; 47: 243–271
   PubMedGoogle Scholar
• Babior BM. Phagocytes and oxidative stress. Am J Med 2000; 109: 33–44
   PubMed Web of Science ®Google Scholar
• Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998; 92: 3007–3017
   PubMed Web of Science ®Google Scholar
• De Lucca AJ, Walsh TJ. Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrob Agents Chemother 1999; 43: 1–11
   PubMed Web of Science ®Google Scholar
• Ramanathan B, Davis EG, Ross CR, Blecha F. Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity. Microbes Infect 2002; 4: 361–372
   PubMed Web of Science ®Google Scholar
• Yang D, Biragyn A, Kwak LW, Oppenheim JJ. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol 2002; 23: 291–296
   PubMed Web of Science ®Google Scholar
• Romani L. Immunity to fungal infections. Nat Rev Immunol 2004; 4: 1–23
   PubMed Web of Science ®Google Scholar
• Lamaris GA, Chamilos G, Lewis RE, Kontoyiannis DP. Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster. J Infect Dis 2007; 196: 1860–1864
   Web of Science ®Google Scholar
• Bittencourt VC, Figueiredo RT, da Silva RB, et al. An alpha-glucan of Pseudallescheria boydii is involved in fungal phagocytosis and Toll-like receptor activation. J Biol Chem 2006; 281: 22614–22623
   PubMed Web of Science ®Google Scholar
• Lamaris GA, Lewis RE, Chamilos G, et al. Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. J Infect Dis 2008; 198: 186–192
   PubMed Web of Science ®Google Scholar
• Hohl TM, Feldmesser M, Perlin DS, Pamer EG. Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure. J Infect Dis 2008; 198: 176–185
   PubMed Web of Science ®Google Scholar
• Ben-Ami R, Lewis RE, Kontoyiannis DP. Immunocompromised hosts: immunopharmacology of modern antifungals. Clin Infect Dis 2008; 47: 226–235
   PubMed Web of Science ®Google Scholar
• Gil-Lamaignere C, Roilides E, Lyman CA, et al. Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury. Infect Immun 2003; 71: 6472–6478
   PubMed Web of Science ®Google Scholar
• Gil-Lamaignere C, Maloukou A, Rodriguez-Tudela JL, Roilides E. Human phagocytic cell responses to Scedosporium prolificans. Med Mycol 2001; 39: 169–175
   PubMed Web of Science ®Google Scholar
• Jacobson ES. Pathogenic roles for fungal melanins. Clin Microbiol Rev 2000; 13: 708–717
   PubMed Web of Science ®Google Scholar
• Nosanchuk JD, Casadevall A. Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds. Antimicrob Agents Chemother 2006; 50: 3519–3528
   PubMed Web of Science ®Google Scholar
• Dadachova E, Bryan RA, Huang X, et al. Ionizing radiation changes the electronic properties of melanin and enhances the growth of melanized fungi. PLoS ONE 2007; 2: e457
   PubMed Web of Science ®Google Scholar
• Jacobson ES, Hove E, Emery HS. Antioxidant function of melanin in black fungi. Infect Immun 1995; 63: 4944–4945
   PubMed Web of Science ®Google Scholar
• Schnitzler N, Peltroche-Llacsahuanga H, Bestier N, et al. Effect of melanin and carotenoids of Exophiala (Wangiella) dermatitidis on phagocytosis, oxidative burst, and killing by human neutrophils. Infect Immun 1999; 67: 94–101
   PubMed Web of Science ®Google Scholar
• Wang Y, Casadevall A. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect Immun 1994; 62: 3004–3007
   PubMed Web of Science ®Google Scholar
• Ruiz-Diez B, Martinez-Suarez JV. Isolation, characterization, and antifungal susceptibility of melanin-deficient mutants of Scedosporium prolificans. Curr Microbiol 2003; 46: 228–232
   PubMed Web of Science ®Google Scholar
• Warris A, Netea MG, Verweij PE, et al. Cytokine responses and regulation of interferon-gamma release by human mononuclear cells to Aspergillus fumigatus and other filamentous fungi. Med Mycol 2005; 43: 613–621
   PubMed Web of Science ®Google Scholar
• Brieland JK, Jackson C, Menzel F, et al. Cytokine networking in lungs of immunocompetent mice in response to inhaled Aspergillus fumigatus. Infect Immun 2001; 96: 1554–1560
   Google Scholar
• Steinbach WJ, Perfect JR. Scedosporium species infections and treatments. J Chemother 2003; 15(Suppl. 2)16–27
   PubMed Web of Science ®Google Scholar
• Winn RM, Gil-Lamaignere C, Roilides E, et al. Effects of interleukin-15 on antifungal responses of human polymorphonuclear leukocytes against Fusarium spp. and Scedosporium spp. Cytokine 2005; 31: 1–8
   PubMedGoogle Scholar
• Chaves MM, Silvestrini AA, Silva-Teixeira DN, Nogueira-Machado JA. Effect in vitro of gamma interferon and interleukin-10 on generation of oxidizing species by human granulocytes. Inflamm Res 1996; 45: 313–315
   Google Scholar
• Amezaga MA, Bazzoni F, Sorio C, Rossi F, Cassatella MA. Evidence for the involvement of distinct signal transduction pathways in the regulation of constitutive and interferon gamma-dependent gene expression of NADPH oxidase components (gp91-phox, p47-phox, and p22-phox) and high-affinity receptor for IgG (Fc gamma R-I) in human polymorphonuclear leukocytes. Blood 1992; 79: 735–744
   Google Scholar
• Cassatella MA, Bazzoni F, Flynn RM, et al. Molecular basis of interferon-gamma and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components. J Biol Chem 1990; 265: 20241–20246
   PubMed Web of Science ®Google Scholar
• Rodriguez-Adrian LJ, Grazziutti ML, Rex JH, Anaissie EJ. The potential role of cytokine therapy for fungal infections in patients with cancer: is recovery from neutropenia all that is needed?. Clin Infect Dis 1998; 26: 1270–1278
   PubMed Web of Science ®Google Scholar
• Giles FJ. Monocyte-macrophages, granulocyte-macrophage colony-stimulating factor, and prolonged survival among patients with acute myeloid leukemia and stem cell transplants. Clin Infect Dis 1998; 26: 1282–1289
   PubMed Web of Science ®Google Scholar
• Armitage JO. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1998; 92: 4491–4508
   PubMed Web of Science ®Google Scholar
• Gil-Lamaignere C, Winn RM, Simitsopoulou M, et al. Inteferon gamma and granulocyte-macrophage colony-stimulating factor augment the antifungal activity of human polymorphonuclear leukocytes against Scedosporium spp.: comparison with Aspergillus spp. Med Mycol 2005; 43: 253–260
   PubMed Web of Science ®Google Scholar
• Simitsopoulou M, Gil-Lamaignere C, Avramidis N, et al. Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans. Antimicrob Agents Chemother 2004; 48: 3801–3805
   PubMed Web of Science ®Google Scholar
• Antachopoulos C, Roilides E. Cytokines and fungal infections. Br J Haematol 2005; 129: 583–596
   PubMed Web of Science ®Google Scholar
• Hamood M, Bluche PF, De Vroey C, et al. Effects of recombinant human granulocyte-colony stimulating factor on neutropenic mice infected with Candida albicans: acceleration of recovery from neutropenia and potentiation of anti-C. albicans resistance. Mycoses 1994; 37: 93–99
   PubMed Web of Science ®Google Scholar
• Muranaka H, Suga M, Nakagawa K, et al. Effects of granulocyte and granulocyte-macrophage colony-stimulating factors in a neutropenic murine model of trichosporonosis. Infect Immun 1997; 65: 3422–3429
   PubMed Web of Science ®Google Scholar
• Graybill JR, Bocanegra R, Najvar LK, Loebenberg D, Luther MF. Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression. Antimicrob Agents Chemother 1998; 42: 2467–2473
   PubMed Web of Science ®Google Scholar
• Ortoneda M, Capilla J, Pujol I, et al. Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans. J Antimicrob Chemother 2002; 49: 525–529
   PubMed Web of Science ®Google Scholar
• Ortoneda M, Capilla J, Pastor FJ, Serena C, Guarro J. Interaction of granulocyte colony-stimulating factor and high doses of liposomal amphotericin B in the treatment of systemic murine scedosporiosis. Diagn Microbiol Infect Dis 2004; 50: 247–251
   PubMed Web of Science ®Google Scholar
• Gil-Lamaignere C, Roilides E, Maloukou A, et al. Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum. J Antimicrob Chemother 2002; 50: 1027–1030
   PubMed Web of Science ®Google Scholar
• Gil-Lamaignere C, Roilides E, Mosquera J, Maloukou A, Walsh TJ. Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum. Antimicrob Agents Chemother 2002; 46: 2234–2237
   PubMed Web of Science ®Google Scholar